These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss. Gouveris H, Schuler-Schmidt W, Mewes T, Mann W. Otol Neurotol; 2011 Jul; 32(5):756-60. PubMed ID: 21646933 [Abstract] [Full Text] [Related]
11. Clinical practice guideline: benign paroxysmal positional vertigo. Bhattacharyya N, Baugh RF, Orvidas L, Barrs D, Bronston LJ, Cass S, Chalian AA, Desmond AL, Earll JM, Fife TD, Fuller DC, Judge JO, Mann NR, Rosenfeld RM, Schuring LT, Steiner RW, Whitney SL, Haidari J, American Academy of Otolaryngology-Head and Neck Surgery Foundation. Otolaryngol Head Neck Surg; 2008 Nov; 139(5 Suppl 4):S47-81. PubMed ID: 18973840 [Abstract] [Full Text] [Related]
15. Comparison of two different steroid treatments with hyperbaric oxygen for idiopathic sudden sensorineural hearing loss. Sevil E, Bercin S, Muderris T, Gul F, Kiris M. Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2419-26. PubMed ID: 26538427 [Abstract] [Full Text] [Related]
16. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Plaza G, Herráiz C. Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569 [Abstract] [Full Text] [Related]
17. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Battaglia A, Burchette R, Cueva R. Otol Neurotol; 2008 Jun; 29(4):453-60. PubMed ID: 18401285 [Abstract] [Full Text] [Related]